###begin article-title 0
###xml 87 95 87 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SERPINA1</italic>
Prevalence of genetic polymorphisms in the promoter region of the alpha-1 antitrypsin (SERPINA1) gene in chronic liver disease: a case control study
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
###xml 62 72 62 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(p.E342K) </italic>
###xml 85 95 85 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(p.E264V) </italic>
###xml 102 111 102 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SERPINA1 </italic>
###xml 268 277 268 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c.-1973T </italic>
###xml 278 280 278 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C </italic>
###xml 308 317 308 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SERPINA1 </italic>
###xml 375 383 <span type="species:ncbi:9606">patients</span>
###xml 415 423 <span type="species:ncbi:9606">patients</span>
Alpha-1 antitrypsin (A1AT) deficiency, caused by the Z allele (p.E342K) and S allele (p.E264V) in the SERPINA1 gene, can induce liver and pulmonary disease. Different mechanisms appear to be responsible for the pathogenesis of these divergent disease expressions. The c.-1973T >C polymorphism located in the SERPINA1 promoter region is found more frequent in A1AT deficiency patients with liver disease compared to patients with pulmonary disease, but data are lacking regarding contribution to the development of liver diseases caused by other aetiologies.
###end p 2
###begin title 3
Aim
###end title 3
###begin p 4
###xml 27 36 27 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c.-1973T </italic>
###xml 37 38 37 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 77 85 <span type="species:ncbi:9606">patients</span>
To study the prevalence of c.-1973T >C, Z allele and S allele in a cohort of patients with liver disease of various aetiologies compared with healthy controls and to evaluate its effect on disease progression.
###end p 4
###begin title 5
Methods
###end title 5
###begin p 6
###xml 135 144 135 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c.-1973T </italic>
###xml 145 147 145 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C </italic>
###xml 187 196 187 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SERPINA1 </italic>
###xml 15 23 <span type="species:ncbi:9606">patients</span>
A total of 297 patients with liver disease from various aetiologies and 297 age and gender matched healthy controls were included. The c.-1973T >C polymorphism and Z and S alleles of the SERPINA1 gene were analyzed by real-time PCR.
###end p 6
###begin title 7
Results
###end title 7
###begin p 8
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c.-1973T </italic>
###xml 10 12 10 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C </italic>
###xml 148 157 148 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c.-1973T </italic>
###xml 158 160 158 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C </italic>
###xml 310 318 310 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c.-1973 </italic>
###xml 46 54 <span type="species:ncbi:9606">patients</span>
###xml 204 212 <span type="species:ncbi:9606">patients</span>
###xml 404 412 <span type="species:ncbi:9606">patients</span>
c.-1973T >C was similarly distributed between patients with liver disease of various origins and healthy controls. Furthermore, the distribution of c.-1973T >C was independent from aetiology subgroup. In patients with liver disease mean ages at of onset of liver disease were 44.4, 42.3 and 40.7 years for the c.-1973 T/T, T/C and C/C genotype respectively (NS). S allele heterozygosity was increased in patients with drug induced liver injury (DILI), (OR 4.3; 95%CI 1.1-17.2).
###end p 8
###begin title 9
Conclusion
###end title 9
###begin p 10
###xml 14 23 14 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c.-1973T </italic>
###xml 24 26 24 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C </italic>
In our study, c.-1973T >C polymorphism was not a risk factor for liver disease of various aetiologies. In addition, S allele heterozygosity might contribute to the development of DILI.
###end p 10
###begin title 11
Background
###end title 11
###begin p 12
###xml 341 342 341 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 343 344 343 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 443 452 443 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SERPINA1 </italic>
###xml 552 560 552 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p.E342K </italic>
###xml 586 594 586 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p.E264V </italic>
###xml 633 634 633 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 734 735 734 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 784 785 784 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 707 715 <span type="species:ncbi:9606">children</span>
Alpha-1 antitrypsin (A1AT) deficiency is a hereditary disease and can induce end-organ damage caused by defective A1AT protein processing. Liver disease in A1AT deficiency is caused by hepatic accumulation of the A1AT protein and pulmonary disease is induced by an impaired protection against neutrophil elastase due to decreased serum A1AT[1,2]. The A1AT protein is encoded by the protease inhibitor (Pi) locus located on chromosome 14q32.1 (SERPINA1 gene). In Western Europe, A1AT deficiency most commonly results from presence of 2 genetic variants p.E342K (denoted as Z allele) and p.E264V (commonly referred to as the S allele)[3]. Liver disease in A1AT deficiency has a bimodal presentation affecting children in neonatal life [4] and, less commonly, adults in late middle life[5].
###end p 12
###begin p 13
###xml 310 311 310 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 528 529 528 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 645 646 645 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 65 73 <span type="species:ncbi:9606">patients</span>
###xml 243 250 <span type="species:ncbi:9606">persons</span>
###xml 259 266 <span type="species:ncbi:4097">tobacco</span>
###xml 574 582 <span type="species:ncbi:9606">patients</span>
It is unclear why A1AT deficiency leads to liver disease in some patients and lung disease in others. It appears that environmental factors are in part responsible for this difference. Pulmonary disease develops preferably in homozygous Pi ZZ persons who are tobacco smokers or are exposed to airway irritants[6]. Indeed, smoking is an established risk factor for lung disease as A1AT deficient smokers will develop emphysema at considerable younger age, while non-smokers are at risk for liver disease developing later in life[7]. Some 32-37% of A1AT deficient non-smoking patients will die as a result of A1AT deficiency induced liver disease[8].
###end p 13
###begin p 14
###xml 329 330 329 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 456 466 456 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g.126076T </italic>
###xml 467 479 467 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C (c.-1973T </italic>
###xml 480 483 480 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C; </italic>
###xml 520 528 520 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SERPINA1</italic>
###xml 681 683 681 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
Apart from environmental factors there is some evidence that genetic factors modify the risk for A1AT deficiency related end-organ damage. For example, 72% of siblings of probands with A1AT deficiency related liver disease suffered from liver disease, which was concordant for severity in 29%, while 28% had no liver involvement[9]. This suggests presence of genetic modifiers. Indeed a recent study identified a novel single nucleotide polymorphism (SNP) g.126076T >C (c.-1973T >C; rs8004738) in the promoter region of SERPINA1. It appeared that the SNP was enriched (15.5%) in a cohort of A1AT Pi ZZ homozygotes with liver disease relative to those with pulmonary disease (6.5%)[10].
###end p 14
###begin p 15
###xml 69 78 69 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c.-1973T </italic>
###xml 79 81 79 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C </italic>
###xml 254 263 254 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c.-1973T </italic>
###xml 264 265 264 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 267 275 267 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p.E342K </italic>
###xml 290 298 290 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p.E264V </italic>
###xml 157 165 <span type="species:ncbi:9606">patients</span>
###xml 338 346 <span type="species:ncbi:9606">patients</span>
As a result of the above-mentioned observations we hypothesized that c.-1973T >C polymorphism affects susceptibility for the progression of liver disease in patients with liver disease of various aetiologies. Therefore we investigated the association of c.-1973T >C, p.E342K (Z allele) and p.E264V (S allele) polymorphisms in a cohort of patients with liver disease of various aetiologies compared with healthy controls and evaluated its consequence on course of disease.
###end p 15
###begin title 16
Methods
###end title 16
###begin title 17
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients
###end title 17
###begin p 18
###xml 854 855 848 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
###xml 13 21 <span type="species:ncbi:9606">patients</span>
###xml 223 230 <span type="species:ncbi:9606">persons</span>
###xml 257 265 <span type="species:ncbi:9606">patients</span>
###xml 301 308 <span type="species:ncbi:9606">patient</span>
###xml 612 620 <span type="species:ncbi:9606">patients</span>
###xml 736 744 <span type="species:ncbi:9606">patients</span>
We recruited patients with various liver disorders, visiting the outpatient clinic of the Department of Gastroenterology and Hepatology of the Radboud University Nijmegen Medical Center. In addition, age and gender matched persons who were unrelated to our patients served as healthy controls. In the patient population, clinical and demographic data including age, sex, age at first presentation of liver disease, aetiology of liver disease and presence or absence of cirrhosis were obtained. The absence of liver disease in our control population was established on the basis of self-reporting and none of the patients used any medication. Whole blood samples were stored at -20degreesC. Altogether the study population comprised 297 patients with various aetiologies of liver disease and 297 controls. Clinical and demographic data are given in Table 1. The study was approved by the local ethical committee (Medical Ethical Committee of the Radboud University Nijmegen Medical Center) and all subjects gave their informed consent.
###end p 18
###begin p 19
###xml 28 36 <span type="species:ncbi:9606">patients</span>
Baseline characteristics of patients and controls.
###end p 19
###begin p 20
###xml 0 3 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 6 23 <span type="species:ncbi:11103">hepatitis C virus</span>
###xml 116 119 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 122 139 <span type="species:ncbi:10407">hepatitis B virus</span>
HCV = hepatitis C virus, AIH/PSC/PBC = autoimmune hepatitis/primary biliary cirrhosis/primary sclerosing cirrhosis, HBV = hepatitis B virus, NASH = non-alcoholic steato hepatitis
###end p 20
###begin title 21
Laboratory
###end title 21
###begin p 22
###xml 120 129 120 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c.-1973T </italic>
###xml 130 132 130 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C </italic>
###xml 145 153 145 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p.E342K </italic>
###xml 193 201 193 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p.E264V </italic>
###xml 254 263 254 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SERPINA1 </italic>
###xml 642 643 642 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S1">1</xref>
###xml 858 860 858 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
DNA was isolated from peripheral blood using the High Pure PCR Template preparation kit (Roche, Mannheim, Germany). The c.-1973T >C (rs8004738), p.E342K (Z allele; c.1024G > A; rs28929474) and p.E264V (S allele; c.791A > T; rs17580) polymorphisms of the SERPINA1 gene were analyzed by real-time polymerase chain reaction (PCR) using a dual-color, allele-specific discrimination assay with fluorescent labelled probes on the iCycler iQ Multicolour real-time detection system (Bio-Rad Laboratories Inc, Hercules, CA, USA). Primer and probe sequences (Sigma, St Louis, MO, USA) used for PCR and real time detection are listed in additional file 1. All of the genotyping results in the control population were in the Hardy-Weinberg equilibrium. Haplotypes and diplotypes were determined using the Partition-Ligation-Expectation-Maximization (PLEM) 1.0 software [11].
###end p 22
###begin title 23
Statistical analysis
###end title 23
###begin p 24
###xml 512 520 512 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c.-1973 </italic>
###xml 838 847 838 847 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c.-1973T </italic>
###xml 848 850 848 850 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C </italic>
Baseline characteristics, differences in allele frequency, diplotypes and haplotypes were analyzed using student t-tests, Pearson chi-squared test and Fisher's exact test when appropriate. Odds Ratio's (OR) were calculated for the association between the studied polymorphisms and the presence of liver disease. In addition we calculated OR's for the association between the 3 polymorphisms and all different subgroup aetiologies. We analyzed differences in age at onset of liver disease between the 3 different c.-1973 genotypes using ANOVA. All statistical analyses were performed using GraphPad Prism Version 4.02 (GraphPad Software Inc., San Diego, CA, USA). A two-sided p-value of < 0.05 was considered statistically significant. Post-hoc power calculation showed the study being adequate powered (88%) to negate our hypothesis that c.-1973T >C is associated with liver disease of various aetiologies (alpha = 0.05, difference in group proportions 10% (20% and 30%)). Power calculations were performed using nQuery Advisor 4.0 software (Statistical Solutions Ltd, Cork, Ireland). Linkage disequilibrium (LD) values were performed with Haploview 4.0 software.
###end p 24
###begin title 25
Results
###end title 25
###begin title 26
c.-1973T > C polymorphism
###end title 26
###begin p 27
###xml 4 13 4 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c.-1973T </italic>
###xml 14 16 14 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C </italic>
###xml 144 151 144 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c.-1973</italic>
###xml 249 250 249 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
###xml 283 292 283 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c.-1973T </italic>
###xml 293 295 293 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C </italic>
###xml 469 477 469 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c.-1973 </italic>
###xml 586 587 586 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2</xref>
###xml 612 621 612 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c.-1973T </italic>
###xml 622 624 622 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C </italic>
###xml 49 57 <span type="species:ncbi:9606">patients</span>
###xml 185 193 <span type="species:ncbi:9606">patients</span>
###xml 451 459 <span type="species:ncbi:9606">patients</span>
The c.-1973T >C polymorphism distribution in 297 patients with liver disease due to various aetiologies was in line with 297 healthy controls. (c.-1973: T/T 32%, T/C 44% and C/C 24% in patients and T/T 30%, T/C 50% and C/C 20% in controls). (Figure 1) We found no association of the c.-1973T >C polymorphism with any of the distinct liver diseases investigated. Next, we observed that mean age at onset of liver disease was non-significantly lower in patients with the c.-1973 C/C allele, as mean ages of onset of liver disease were 44.4 (T/T), 42.3 (T/C) and 40.7 (C/C) years. (Figure 2) Further, possession of c.-1973T >C polymorphism had no influence on the presence of cirrhosis.
###end p 27
###begin p 28
###xml 20 29 20 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c.-1973T </italic>
###xml 30 32 30 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C </italic>
###xml 0 116 0 116 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Distribution of the <italic>c.-1973T </italic>&gt;<italic>C </italic>genotypes in 297 patients with liver disease of various aetiologies and 297 controls</bold>
###xml 49 57 <span type="species:ncbi:9606">patients</span>
Distribution of the c.-1973T >C genotypes in 297 patients with liver disease of various aetiologies and 297 controls.
###end p 28
###begin p 29
###xml 72 81 72 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c.-1973T </italic>
###xml 82 84 82 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C </italic>
###xml 0 93 0 93 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Age at onset of liver disease in 297 patients arranged to the different <italic>c.-1973T </italic>&gt;<italic>C </italic>genotypes</bold>
###xml 37 45 <span type="species:ncbi:9606">patients</span>
Age at onset of liver disease in 297 patients arranged to the different c.-1973T >C genotypes.
###end p 29
###begin title 30
Z (p.E342K) allele and S (p.E264V) allele heterozygosity
###end title 30
###begin p 31
###xml 67 75 <span type="species:ncbi:9606">patients</span>
###xml 382 390 <span type="species:ncbi:9606">patients</span>
###xml 453 461 <span type="species:ncbi:9606">patients</span>
We observed a similar Z allele and S allele heterozygosity rate in patients and controls (Z allele: 3.0% and 4.7%; S allele: 6.7% and 8.0%). The distribution of Z allele heterozygosity was similar among all liver diseases of various aetiologies. In contrast, S allele heterozygosity was more frequently present in drug induced liver injury (DILI) compared with healthy controls (11 patients, 27% vs 8%; OR 4.27; 95%CI 1.06-17.15). A total of 8 wildtype patients developed DILI likely due to clavulanic acid (n = 3), azatioprine, sulfasalazine, pantoprazole, methotrexate and quetiapine; addionally, the S allele heterozygotes had DILI caused by anaesthetic compounds (isoflurane/nestonal), clavulanic acid and celecoxib. Lastly, age at onset of liver disease was independent of Z or S allele heterozygosity as mean ages were 48.3 (Z allele), 43.2 (S allele) and 42.4 (wildtypes) years.
###end p 31
###begin title 32
Haplotyping/diplotyping
###end title 32
###begin p 33
###xml 417 418 417 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">2</xref>
###xml 471 480 471 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SERPINA1 </italic>
###xml 556 557 556 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3</xref>
###xml 189 197 <span type="species:ncbi:9606">patients</span>
###xml 303 311 <span type="species:ncbi:9606">patients</span>
###xml 518 526 <span type="species:ncbi:9606">patients</span>
Based on the 3 polymorphisms tested, haplotype and diplotype analysis were performed. A total of 11 diplotypes could be distinguished. We could not detect differences in diplotypes between patients with liver disease of various etiologies and controls. Only the CTG haplotype was more frequent found in patients with DILI, according to the above-described association between S allele heterozygosity and DILI. (Table 2) Finally, linkage disequilibrium (LD) between the 3 SERPINA1 alleles was absent. This was true for patients as well as controls. (Figure 3)
###end p 33
###begin p 34
###xml 14 22 <span type="species:ncbi:9606">patients</span>
Diplotypes in patients with liver disease of various aetiology and healthy controls
###end p 34
###begin p 35
###xml 18 27 18 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c.-1973T </italic>
###xml 28 29 28 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 56 65 56 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c.-1973T </italic>
###xml 66 67 66 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 108 112 108 112 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bold</bold>
Order of alleles: c.-1973T >C- c.791A > T - c.1024G > A/c.-1973T >C- c.791A > T - c.1024G > A (mutations in bold)
###end p 35
###begin p 36
###xml 44 53 44 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SERPINA1 </italic>
###xml 0 57 0 57 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Linkage disequilibrium (LD) plot across the <italic>SERPINA1 </italic>gene</bold>
###xml 112 121 112 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SERPINA1 </italic>
###xml 161 168 161 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p.E342K</italic>
###xml 174 182 174 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p.E264V </italic>
###xml 190 199 190 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c.-1973T </italic>
###xml 200 201 200 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 248 250 248 250 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sup>
###xml 59 67 <span type="species:ncbi:9606">Patients</span>
Linkage disequilibrium (LD) plot across the SERPINA1 gene. Patients. Controls. The box at the top indicates the SERPINA1 gene with the 3 investigated SNP's (1 = p.E342K, 2 = p.E264V and 3 = c.-1973T >C). The LD plot is based on the measurement of R2 (values x 0.01). Each diamond indicates the pair wise magnitude of LD. (LD: linkage disequilibrium is the non-random association of alleles at two or more loci. LD describes a situation in which some combinations of alleles or genetic markers occur more or less frequently in a population than would be expected from a random formation of haplotypes from alleles based on their frequencies.)
###end p 36
###begin title 37
Discussion
###end title 37
###begin p 38
###xml 33 51 33 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SERPINA1 c.-1973T </italic>
###xml 52 54 52 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C </italic>
###xml 290 292 290 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 339 348 339 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c.-1973T </italic>
###xml 349 351 349 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C </italic>
###xml 432 441 432 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c.-1973T </italic>
###xml 442 444 442 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C </italic>
###xml 564 572 564 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c.-1973 </italic>
###xml 603 611 603 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c.-1973 </italic>
###xml 678 687 678 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c.-1973T </italic>
###xml 688 690 688 690 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C </italic>
###xml 57 65 <span type="species:ncbi:9606">patients</span>
###xml 183 190 <span type="species:ncbi:9606">patient</span>
###xml 546 554 <span type="species:ncbi:9606">patients</span>
###xml 851 859 <span type="species:ncbi:9606">patients</span>
###xml 1002 1010 <span type="species:ncbi:9606">patients</span>
We show that the distribution of SERPINA1 c.-1973T >C in patients with liver disease from various aetiologies is similar compared to healthy controls. The genotype frequencies in the patient and control groups were in line with those from the HapMap database (TT 30%, T/C 45% and C/C 25%) [12]. Moreover, we found that the distribution of c.-1973T >C is independent from aetiology of the liver disease. We also examined whether the c.-1973T >C polymorphism affected age at onset of liver disease. We found a non-significant lower age at onset in patients with the c.-1973 C/C genotype compared to other c.-1973 genotypes. In addition, we could not demonstrate an association of c.-1973T >C on severity of liver disease e.g. cirrhosis. We also investigated other SERPINA1 variants and found that there was no increased prevalence of Z and S alleles in patients with liver disease of various aetiologies compared with healthy controls, even though we observed an enrichment of S allele heterozygosity in patients with DILI.
###end p 38
###begin p 39
###xml 49 58 49 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c.-1973T </italic>
###xml 59 61 59 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C </italic>
###xml 173 182 173 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c.-1973T </italic>
###xml 183 185 183 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C </italic>
###xml 325 327 325 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 628 637 628 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c.-1973T </italic>
###xml 638 640 638 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C </italic>
###xml 744 746 744 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 775 784 775 784 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c.-1973T </italic>
###xml 785 787 785 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C </italic>
###xml 1079 1081 1079 1081 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 389 397 <span type="species:ncbi:9606">patients</span>
###xml 643 651 <span type="species:ncbi:9606">patients</span>
###xml 1030 1038 <span type="species:ncbi:9606">patients</span>
Other investigators have studied the presence of c.-1973T >C and A1AT deficiency and chronic obstructive pulmonary disease (COPD). Chappell et al. reported an enrichment of c.-1973T >C in homozygous Pi ZZ neonates with hepatitis (15.5%) compared to homozygous Pi ZZ controls (adults with COPD and unaffected subjects) (6.5%)[10]. Since our study population consisted for a large extent of patients and controls with the Pi MM genotype (wildtypes) and hardly any subjects with Z and S allele heterozygosity, we cannot compare our data with the results of the above mentioned study. Another study showed a decreased prevalence of c.-1973T >C in patients with COPD (48.7%) compared to controls (52.2%), suggesting a protective effect against COPD[13]. It might be possible that c.-1973T >C influences the genesis of liver disease in childhood, in line with a recently published report implicating that a variant of the endoplasmic reticulum mannosidase I (ERManI) gene is associated with an early onset of end-stage liver disease in patients with homozygous (Pi ZZ) A1AT deficiency[14].
###end p 39
###begin p 40
###xml 199 201 199 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 202 204 202 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 484 486 484 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 602 604 602 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 143 146 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 288 296 <span type="species:ncbi:9606">patients</span>
###xml 437 442 <span type="species:ncbi:10090">mouse</span>
###xml 593 600 <span type="species:ncbi:9606">patient</span>
Our data were in contrast with other reports as Z and S allele heterozygosity were previously associated with (end-stage) liver disease due to HCV, alcoholic liver disease and cryptogenic cirrhosis [15-19] and not with DILI. We found a higher frequency of S allele heterozygosity in DILI patients. Indeed, experimental evidence supports a relation between A1AT deficiency and DILI as administration of indomethacin in a homozygous Pi ZZ mouse model leads to increased hepatic injury [20] and a case report described prochlorperazine induced liver injury in a homozygous (Pi ZZ) A1AT deficient patient [21].
###end p 40
###begin p 41
###xml 48 57 48 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c.-1973T </italic>
###xml 58 60 58 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C </italic>
###xml 301 308 301 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c.1-44 </italic>
###xml 465 467 462 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 523 525 520 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 610 612 607 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 416 424 <span type="species:ncbi:9606">patients</span>
###xml 480 488 <span type="species:ncbi:9606">patients</span>
We could not demonstrate an association between c.-1973T >C and the presence of cirrhosis. There have been several genetic case control studies that have attempted to detect associations between genetic variations and liver fibrosis. For example, the combination of angiotensinogen (ATG) gene variant c.1-44 and transforming growth factor beta (TGFbeta1) p.R25P is associated with advanced hepatic fibrosis in obese patients with non alcoholic fatty liver disease [22] but not in patients with other chronic liver diseases[23]. Lastly, matrix metalloproteinase (MMP)-7(Asp-137) confers risk of liver cirrhosis[24].
###end p 41
###begin p 42
###xml 243 252 243 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c.-1973T </italic>
###xml 253 255 253 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C </italic>
###xml 422 431 422 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c.-1973T </italic>
###xml 432 434 432 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C </italic>
###xml 512 521 512 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c.-1973T </italic>
###xml 522 524 522 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C </italic>
###xml 92 99 <span type="species:ncbi:9606">patient</span>
Our study comes with limitations. Our cohort could have suffered from selection bias due to patient recruitment in a tertiary referral centre. The strength of our study is the sufficiently power to negate a 10% difference in prevalence of the c.-1973T >C polymorphism between groups. However, the study lacks power to demonstrate smaller differences and to perform a thorough subgroup analysis. Further research regarding c.-1973T >C should include homozygous Pi ZZ adults with liver disease to evaluate whether c.-1973T >C is a risk factor for a hepatic expression of A1AT deficiency.
###end p 42
###begin title 43
Conclusion
###end title 43
###begin p 44
###xml 36 45 36 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c.-1973T </italic>
###xml 46 48 46 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C </italic>
We demonstrated that, in our study, c.-1973T >C polymorphism was not associated with liver disease of various aetiologies. In addition, S allele heterozygosity might be a risk factor for the genesis of DILI.
###end p 44
###begin title 45
Competing interests
###end title 45
###begin p 46
The authors declare that they have no competing interests.
###end p 46
###begin title 47
Authors' contributions
###end title 47
###begin p 48
KK carried out the molecular genetic studies, participated in the design of the study, participated in the statistical analysis and drafted the manuscript. RM generated the sequence alignment, constructed the diplo- and haplotypes and participated in the molecular genetic studies. MO participated in the statistical analysis and read previous drafts of the manuscript. JD, the principle investigator participated in the design of the study and coordinated the study. All authors read and approved the final version.
###end p 48
###begin title 49
Pre-publication history
###end title 49
###begin p 50
The pre-publication history for this paper can be accessed here:
###end p 50
###begin p 51

###end p 51
###begin title 52
Supplementary Material
###end title 52
###begin title 53
Additional file 1
###end title 53
###begin p 54
Overview of primers and probes used for real time PCR reactions.
###end p 54
###begin p 55
Click here for file
###end p 55
###begin title 56
Acknowledgements
###end title 56
###begin p 57
Karin F Kok is a recipient of the eALTA award 2007.
###end p 57
###begin p 58
Joost PH Drenth is supported by a VIDI fellowship from the Netherlands Organization for Scientific Research (NWO). These funding sources did not participate in the design of the study, nor in the collection, analysis, and interpretation of data, nor in the writing of the manuscript and did also not participate in the decision to submit the manuscript for publication.
###end p 58
###begin article-title 59
Alpha1-antitrypsin deficiency
###end article-title 59
###begin article-title 60
Heterozygous alpha-I antitrypsin deficiency as a co-factor in the development of chronic liver disease: a review
###end article-title 60
###begin article-title 61
Worldwide racial and ethnic distribution of alpha1-antitrypsin deficiency: summary of an analysis of published genetic epidemiologic surveys
###end article-title 61
###begin article-title 62
###xml 80 87 <span type="species:ncbi:9606">infants</span>
Liver disease in alpha1-antitrypsin deficiency detected by screening of 200,000 infants
###end article-title 62
###begin article-title 63
Late manifestation of chronic liver disease in adults with alpha-1-antitrypsin deficiency
###end article-title 63
###begin article-title 64
Effect of age and occupational exposure to airway irritants on lung function in non-smoking individuals with alpha 1-antitrypsin deficiency (PiZZ)
###end article-title 64
###begin article-title 65
Alpha 1-antitrypsin deficiency and liver cirrhosis in adults. An analysis of 35 Swedish autopsied cases
###end article-title 65
###begin article-title 66
Clinical course and prognosis of never-smokers with severe alpha-1-antitrypsin deficiency (PiZZ)
###end article-title 66
###begin article-title 67
Variable degree of liver involvement in siblings with PiZZ alpha-1-antitrypsin deficiency-related liver disease
###end article-title 67
###begin article-title 68
A polymorphism of the alpha1-antitrypsin gene represents a risk factor for liver disease
###end article-title 68
###begin article-title 69
Partition-ligation-expectation-maximization algorithm for haplotype inference with single-nucleotide polymorphisms
###end article-title 69
###begin article-title 70
Reference SNP (refSNP) Cluster report rs 8004738 at
###end article-title 70
###begin article-title 71
Cryptic haplotypes of SERPINA1 confer susceptibility to chronic obstructive pulmonary disease
###end article-title 71
###begin article-title 72
Single Nucleotide Polymorphism-Mediated Translational Suppression of Endoplasmatic Reticulum Mannosidase I Modifeis the Onset of End-Stage Liver Disease in Alpha1-Antitrypsin Deficiency
###end article-title 72
###begin article-title 73
###xml 47 55 <span type="species:ncbi:9606">patients</span>
Heterozygous alpha 1-antitrypsin phenotypes in patients with end stage liver disease
###end article-title 73
###begin article-title 74
Increased risk of chronic liver failure in adults with heterozygous alpha1-antitrypsin deficiency
###end article-title 74
###begin article-title 75
Heterozygous alpha-1 antitrypsin deficiency as an inherited risk factor in the development of chronic liver disease
###end article-title 75
###begin article-title 76
###xml 73 76 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
Influence of alpha-1 antitrypsin heterozygosity on treatment efficacy of HCV combination therapy
###end article-title 76
###begin article-title 77
###xml 114 122 <span type="species:ncbi:9606">patients</span>
The cut-off Value of 100 mg/dL is insufficient to detect heterozygous Alpha-1 Antitrypsin deficient Liver Disease patients
###end article-title 77
###begin article-title 78
###xml 41 47 <span type="species:ncbi:10090">murine</span>
Indomethacin increases liver damage in a murine model of liver injury from alpha-1-antitrypsin deficiency
###end article-title 78
###begin article-title 79
###xml 42 50 <span type="species:ncbi:9606">patients</span>
Prochlorperazine-induced cholestasis in a patients with alpha-1 antitrypsin deficiency
###end article-title 79
###begin article-title 80
Pro-fibrotic polymorphisms predictive of advanced liver fibrosis in the severely obese
###end article-title 80
###begin article-title 81
###xml 115 126 <span type="species:ncbi:11103">hepatitis C</span>
Evaluation of angiotensinogen c.1-44G > A and p.M268T variants as risk factors for fibrosis progression in chronic hepatitis C and liver diseases of various aetiologies
###end article-title 81
###begin article-title 82
A novel nonsynonymous variant of matrix metalloproteinase-7 confers risk of liver cirrhosis
###end article-title 82

